Hal Hirte

Corporate Officer/Principal bij Alethia Biotherapeutics, Inc.

Health Technology

Oorsprong van het eerstegraads netwerk van Hal Hirte

Entiteit	Type entiteit	Industrie
Alethia Biotherapeutics, Inc. Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. 8	Holding Company	Pharmaceuticals: Major	8

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Hal Hirte via zijn persoonlijke netwerk

Onderneming	Sector	Gelieerde personen	Hoofdpost
9342-8530 QUÉBEC INC.	Medical Specialties	Yves Cornellier	Director/Board Member
BELLUS HEALTH	Pharmaceuticals: Major	Julie Laurin	Corporate Officer/Principal
THERATECHNOLOGIES INC.	Pharmaceuticals: Major	Yves Cornellier Ela Borenstein	Corporate Officer/Principal Chief Tech/Sci/R&D Officer
FORTALEZA ENERGY INC.	Oil & Gas Production	Mario Filion	Corporate Officer/Principal
MILESTONE PHARMACEUTICALS INC.	Pharmaceuticals: Major	Ela Borenstein	Director/Board Member
Fasken Martineau DuMoulin LLP Fasken Martineau DuMoulin LLP Miscellaneous Commercial ServicesCommercial Services Fasken Martineau DuMoulin LLP operates as law firm. It provides legal services to construction, financial, insurance, life sciences, corporate, and commercial industry. It offers Labour employment and human rights, litigation and dispute resolution, and privacy and cybersecurity risk management. The company was founded in 1863 and is headquartered in Toronto, Canada.	Miscellaneous Commercial Services	Janique Forget	Corporate Officer/Principal
McGill University	College/University	Gilles Bernard Tremblay	Doctorate Degree
BDC Venture Capital BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada.	Investment Managers	Ela Borenstein	Private Equity Investor
University of Ottawa	College/University	Elizabeth Douville	Doctorate Degree
University of Toronto	College/University	Ela Borenstein	Graduate Degree
University of Western Ontario	College/University	Ela Borenstein	Undergraduate Degree
University of Montréal	College/University	Mario Filion Jacques Jolivet Janique Forget Julie Laurin	Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree
Aegera Therapeutics, Inc. Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.	Biotechnology	Jacques Jolivet	Chief Tech/Sci/R&D Officer
LymphoSign, Inc. LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada.	Biotechnology	Elizabeth Douville	Director/Board Member
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Investment Trusts/Mutual Funds	Jacques Jolivet	Corporate Officer/Principal
GeneChem Management, Inc. GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.	Investment Managers	Elizabeth Douville	Private Equity Investor
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Pharmaceuticals: Major	Jacques Jolivet	Corporate Officer/Principal
Genome Canada Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada.	Miscellaneous Commercial Services	Elizabeth Douville	Chairman
Miles Laboratories, Inc. Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada.	Pharmaceuticals: Major	Yves Cornellier	Corporate Officer/Principal
AgeChem Financial, Inc. AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.	Financial Conglomerates	Elizabeth Douville	Director/Board Member
Abbott Laboratories Ltd. Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937.	Pharmaceuticals: Major	Yves Cornellier	Sales & Marketing
BCF LLP BCF LLP Miscellaneous Commercial ServicesCommercial Services Part of BCF Capital SENC, BCF LLP is a Canadian company that provides legal services. The company is based in Québec, Canada.	Miscellaneous Commercial Services	Janique Forget	Corporate Officer/Principal
SignalGene, Inc.		Mario Filion Gilles Bernard Tremblay	Corporate Officer/Principal Corporate Officer/Principal
Glaxo Canada, Inc.		Yves Cornellier	Corporate Officer/Principal
DAVIDSTEA INC.	Food: Major Diversified	Julie Laurin	Corporate Officer/Principal
AmorChem Financial, Inc. AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada.	Financial Conglomerates	Elizabeth Douville	Chairman
Insitut de Recherche en Immunologie et en Cancérologie Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada.	Miscellaneous Commercial Services	Elizabeth Douville	Chief Executive Officer
Corbin Therapeutics, Inc. Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Corbin Therapeutics, Inc. operates as a biotechnology platform.	Internet Software/Services	Elizabeth Douville	Director/Board Member
Giiant Pharma, Inc. Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021.	Biotechnology	Elizabeth Douville	Director/Board Member
STARPAX BIOPHARMA INC.		Jacques Jolivet	Director/Board Member
Université du Québec à Montréal	College/University	Ela Borenstein	Masters Business Admin